Fosun Pharma Plans Acquisition Of More Israeli Medical Companies

June 11, 2014 | According to a report in Globes, the Shanghai-based Fosun Pharmaceutical Group plans to acquire a number of Israeli medical companies in the coming months. The announcement made by Fosun Pharma CEO Yao Fang, comes one year after the Chinese pharmaceutical giant bought Israeli laser-fat burning company Alma Lasers for $240 million. According to the report, Yao Fang asserts that Fosun Pharma has already begun due diligence processes with a number of Israeli biomedical companies. Fosun Pharma, founded by four students in 1992, is one of China’s largest pharmaceutical companies that develops and manufactures products focused on genetics, biosimilars, diagnostics and healthcare services.